TP53 and acute myeloid leukemia: In Patient 2, PBMCs sampled at AML relapse included a unique oncogenic clone of cells carrying missense mutations in both the SF3B1 gene (c.2098 A > G) and the tumor-suppressor gene TP53 (c.722 C > G) (Fig. 2B).